logo for Tanox

Tanox

Hospitals & Physicians Clinics · Texas, United States · 151 Employees

View Company Info for Free

About

Headquarters

10301 Stella Link Rd Ste 110, Houston, Texas, 7...

Phone Number

(713) 578-4000

Revenue

$10.7 Million

Industry

Hospitals & Clinics Healthcare

Recent News & Media

No recent news or media

Who is Tanox

Tanox is a biotechnology company specializing in the discovery and development of biotherapeutics based on monoclonal antibody technology. The company develops innovative therapeutic agents for the treatment of immune-mediated diseases, inflammation, infectious disease and cancer. Tanox's lead investigational therapy, TNX-355, is a humanized, anti-CD4 monoclonal antibody to treat HIV and AIDS. TNX-355 received Fast Track Status from the U.S. Food and Drug Administration in 2003 and is currently in Phase 2 clinical testing. Tanox's first-approved drug, Xolair (omalizumab), is the first anti-immunoglobulin E (anti-IgE) antibody to be brought to market. Xolair was developed in collaboration with Genentech, Inc. and Novartis Pharma AG and was approved for marketing in the United States in 2003 for adult and adolescent patients with moderate-to-severe, confirmed allergic asthma. Tanox is based in Houston, Texas and maintains a manufacturing facility in San Diego, California.Read more

Tanox's Social MediaPopular SearchesTanox IncTanoxTanox BiosystemsTanox Biotech (Shanghai) Co LtdTanox Biotech (Shanghai) LtdSIC Code 28,283NAICS Code 62,621Show more

Tanox Org Chart

PhoneEmail
Stanley Lewis

Director, Drug Development, Department

PhoneEmail
Sam McKinney

Director, Facilities

PhoneEmail

PhoneEmail

Similar Companies to Tanox

  1. 135
    <$5M

    1

  2. 100
    $20.6M

    2

  3. 357
    $91.2M

    3

  4. 64
    $18M

    4

  5. 69
    $14.9M

    5

  6. 365
    $134.2M

    6

See more similar companies

Tanox Company Metrics

Company Insights
Employee Growth Rate
Acquisitions & Subsidiaries

Jul 18, 2022

TissueInformatics

Jul 18, 2022

Ariosa Diagnostics

Jul 18, 2022

Telavant

Jul 18, 2022

accu-chekassist.com

Jul 18, 2022

Roche Diabetes Care

Apr 10, 2021

Ventana Medical Systems

See More Acquisitions & Subsidiaries

Tanox Tech Stack

A closer look at the technologies used by Tanox

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Frequently Asked Questions regarding Tanox

Where is Tanox located?
Tanox's headquarters are located at 10301 Stella Link Rd Ste 110, Houston, Texas, 77025, United States
What is Tanox's phone number?
Tanox's phone number is (713) 578-4000
What is Tanox's official website?
Tanox's official website is www.tanox.com
What is Tanox's Revenue?
Tanox's revenue is $10.7 Million
What is Tanox's SIC code?
Tanox's SIC: 28,283
What is Tanox's NAICS code?
Tanox's NAICS: 62,621
How many employees does Tanox have?
Tanox has 151 employees
What industry does Tanox belong to?
Tanox is in the industry of: Hospitals & Clinics, Healthcare
What is Tanox competition?
Tanox top competitors include: Lexicon Pharmaceuticals, Abgenix, MacroGenics, Genelabs Technologies
What companies has Tanox acquired?
Tanox has acquired the companies: TissueInformatics, Ariosa Diagnostics, Telavant, accu-chekassist.com
What technology does Tanox use?
Some of the popular technologies that Tanox uses are: Google AdSense, ParkingCrew, nginx
How do I contact Tanox?
Tanox contact info: Phone number: (713) 578-4000 Website: www.tanox.com
What does Tanox do?

Tanox is a biotechnology company specializing in the discovery and development of biotherapeutics based on monoclonal antibody technology. The company develops innovative therapeutic agents for the treatment of immune-mediated diseases, inflammation, infectious disease and cancer. Tanox's lead investigational therapy, TNX-355, is a humanized, anti-... CD4 monoclonal antibody to treat HIV and AIDS. TNX-355 received Fast Track Status from the U.S. Food and Drug Administration in 2003 and is currently in Phase 2 clinical testing. Tanox's first-approved drug, Xolair (omalizumab), is the first anti-immunoglobulin E (anti-IgE) antibody to be brought to market. Xolair was developed in collaboration with Genentech, Inc. and Novartis Pharma AG and was approved for marketing in the United States in 2003 for adult and adolescent patients with moderate-to-severe, confirmed allergic asthma. Tanox is based in Houston, Texas and maintains a manufacturing facility in San Diego, California.Read More

What are Tanox social media links?
Tanox Linkedin page
Is Tanox a public company?
Tanox is private company therefore does not currently have an official ticker symbol
See more information about Tanox

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.